# OnCo record breakthru-medicine (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/breakthru-medicine/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "breakthru-medicine" ;
  schema:name "Breakthru Medicine"@en ;
  schema:description "Breakthru Medicine is a Phoenix cancer drug company working on small molecules, a molecular glue platform and new drug payloads for antibody-drug conjugates. It came out of stealth in January 2026 and aims to start its first clinical trial in early 2027."@en ;
  schema:url <https://onco.cc/companies/breakthru-medicine/>, <https://www.breakthrumed.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.breakthrumed.com/>, <https://www.breakthrumed.com/post/breakthru-medicine-emerges-from-stealth-with-60m-series-a-for-cancer-drug-development> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/molecular-glue-platforms/>, <https://onco.cc/technologies/protac-degrader/> .